Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

UTI Under Lockdown: Same-day Home Test-and-treat Service Launched by Healthy.io


News provided by

Healthy.io

05 May, 2020, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, May 5, 2020 /PRNewswire/ --

  • In a matter of hours and without leaving the house, women can receive a clinical urine test, a GP diagnosis, and antibiotics if needed for urinary tract infections (UTIs) using their smartphone with the Velieve test-and-treat service
  • Velieve uses the smartphone camera and advanced algorithms to read the dipstick and provide a clinical-grade result
  • To meet the urgent need of women during COVID-19 lockdown, Healthy.io is significantly subsidising the service for the next 60 days

Women with a suspected urinary tract infection (UTI) now have access to a clinical-grade test-and-treat service, developed by smartphone urine test pioneers, Healthy.io – all without leaving their home.

The newly launched Velieve service uses a smartphone camera to help diagnose UTIs in just minutes, with antibiotics - if needed - delivered to the door within hours, in a UK first.

Traditionally, women suffering from a UTI need to secure a GP appointment for treatment and if they are prescribed antibiotics, they need to pick the medication up from a pharmacist. Now, women suffering from the painful condition no longer need to leave their homes and risk exposure to COVID-19 for diagnosis and treatment.

With up to 10 million GP appointments a year in the UK, UTIs are one of the most common types of infection. A recent Public Health England survey found that 95% of women who have had a UTI said they needed to see a doctor and 74% had to take antibiotics to treat the painful condition.

In its initial London roll-out, the new Velieve testing kit can be ordered and delivered to any address across the capital within three hours, with courier services offered by Gophr. In partnership with Medicspot, an online clinician will review the dipstick results alongside the patient's symptoms and if a UTI is diagnosed, antibiotic treatment can also be ordered and delivered within another three hours or collected from a pharmacy.

In light of the COVID-19 pandemic and the need among women for a safe, clinically appropriate way to test and treat UTIs from home, Healthy.io has developed this end to end solution and is offering the service at a significantly subsidised cost of £10.00 for the next 60 days. This includes the kit, delivery of the kit to the woman's home within 3 hours, and the online GP consultation. If needed, the cost of antibiotics and delivery of the medication within 3 hours is an additional £15.00.

According to television presenter Cherry Healey: "We all know that feeling when you're about to get a UTI and the symptoms that sneak up on you. I'm so pleased that the Velieve kit and service is available to women who can get the treatment they need as soon as they need it."

"Not only is the test-and-treat kit helping to speed up the time it takes for women with a UTI to get treatment but it's also helping us keep safe during these challenging times."

London-based GP, Dr Nisa Aslam said: "There's no doubt that for many women being able to test and treat a UTI at home will be really very convenient."

"This is even more helpful during the COVID-19 pandemic when many women may be self-isolating, or can't or don't want to go to see or phone their GP practice. They can carry out this test in the comfort of their own homes and get both the test and if needed, the antibiotic treatment delivered to them in a matter of hours."

Katherine Ward, Chief Commercial Officer and Healthy.io's UK Managing Director said: "Now, more than ever, there is an urgent need for home testing. That's why we are thrilled to offer this service to women suffering from UTIs in the midst of the COVID-19 crisis and beyond."

"Healthy.io has a strong history of providing women UTI test-and-treat services and working with retail and NHS partners to bring these products to as many women as possible. Now, Velieve can help women test and treat UTIs without leaving their homes and helps reduce the burden on an already-stretched NHS dealing with the COVID-19 pandemic. Velieve is effective and safe as well as simple and easy to use, with results analysed by a remote clinician and a virtual nurse guiding women throughout the process."

Velieve is the second UTI test-and-treat service offered by Healthy.io. The company launched its pharmacy first test-and-treat service in 2019, which is available at 1,600 retail pharmacies across the UK.

Symptoms of a UTI include pain or a burning sensation when urinating, needing to urinate more often or suddenly, smelly or cloudy urine, blood in urine, lower stomach pain, feeling tired and unwell. If left untreated, a UTI can lead to long-term kidney damage.

Notes to Editors

Velieve can be currently be purchased online at www.velieve.io for residents of London (inside the A406 and A205), with plans to expand to the Greater London area (inside M25) in the coming weeks.

Velieve is the second UTI test-and-treat service offered by Healthy.io. The company launched its pharmacy first test-and-treat service in 2019, which is available at 1,600 retail pharmacies across the UK. The pharmacy first test-and-treat service was also piloted by the NHS in Derbyshire and Nottinghamshire. Results of this pilot are currently being assessed and optimistically could be rolled out nationally.

About Velieve

Velieve is a test-and-treat smartphone-based urine test service for urinary tract infections (UTIs). The home urine screening kit, which is ordered online and delivered to a chosen location within 3 hours, includes a small plastic cup and a single wrapped, three parameter dipstick identical to the one used by clinicians. When the dipstick is submerged in urine, changes in colour indicate the presence or varying levels of indicators needed to test for UTIs.

The test is conducted with guidance from Emily, an in-app nurse who facilitates the test step-by-step. The test is then submitted to a remote clinician for analysis and a result provided to the registered mobile phone user within minutes. Results can also be shared with the patient's clinician. If a test result is positive, antibiotics can be prescribed by the remote clinician and ordered for delivery to the user's chosen location within 3 hours.

For the next 60 days, Velieve retails at £10.00 including delivery of the kit within 3 hours, the remote medical evaluation and the kit itself. Women can choose to have medication delivered to their homes within 3 hours for an additional £15.00 (which includes the cost of medication and home delivery) or to pick up the medication from a pharmacy.

About Healthy.io

Healthy.io, which has pioneered the transformation of the smartphone camera into a medical device, has already partnered with more than 1,600 retail pharmacies across the UK to provide women with a new clinical pathway to test and treat urinary tract infections. In addition, Healthy.io has also partnered with Modality Partnerships - an NHS GP partnership - to provide high-risk populations with a chronic kidney disease early detection service in Yorkshire and Humber. NHS clinicians can also use Healthy.io's dedicated smartphone app and web portal to digitise wound measurement and documentation - two of the most significant challenges in the current process.

Healthy.io was established in 2013 by Yonatan Adiri, the former Chief Technology Officer for the president of Israel, Shimon Peres. Katherine Ward, Healthy.io's Chief Commercial Officer and Managing Director for the UK and Europe, has over 28 years' experience of working in both the public and private healthcare sectors in the UK. Healthy.io has more than 100 employees and is headquartered in Tel Aviv, with offices in the UK and US.

For further information, images or to request an interview please contact:

Imaan Petra
imaan.petra@zpb-associates.com 
+44 7551 007 644

Helen Mooney
helen.mooney@zpb-associates.com 
+44 7849 089 456

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.